The global diabetes devices market was valued at USD 20.92 billion in 2018 and is projected to reach USD 48.35 billion by 2032, reflecting a CAGR of 6.2% over the forecast period. In 2018, North America held the largest share of the market, accounting for 40.54% of the global revenue.
The global diabetes devices market is experiencing steady growth, driven by the rising prevalence of diabetes, increasing health awareness, and advancements in glucose monitoring and insulin delivery technologies. The market includes a wide range of devices, from traditional blood glucose meters to continuous glucose monitors and smart insulin pumps, designed to improve diabetes management and patient outcomes. Growing demand for user-friendly, minimally invasive, and connected devices is further supporting market expansion. With the healthcare industry focusing more on preventive care and personalized treatment, the Diabetes Devices Market is expected to continue its upward trajectory across both developed and emerging regions.
Tap here to continue reading: https://www.fortunebusinessinsights.com/industry-reports/diabetes-devices-market-100803
Market Segmentation
The Diabetes Devices Market is segmented by device type, end user, and technology. Device categories include glucose monitoring devices (such as blood glucose meters and continuous glucose monitors) and insulin delivery systems (including insulin pens, pumps, and smart delivery devices). In terms of technology, the Diabetes Devices Market encompasses both traditional disposable strips and advanced sensor-based technologies. End users in the Diabetes Devices Market span hospitals, homecare settings, and specialized diabetes clinics, ensuring wide accessibility and usage.
List Of Key Companies Covered:
- Hoffmann-La Roche Ltd
- Tandem Diabetes Care, Inc.
- Braun Melsungen AG
- Medtronic
- BD
- Novo Nordisk A/S
- Abbott
- Sanofi
- Other players
Market Growth
The Diabetes Devices Market is experiencing robust growth driven by the increasing prevalence of diabetes worldwide and the growing adoption of continuous glucose monitoring systems. Expansion of self-monitoring blood glucose devices and integration of smart insulin delivery technologies are key factors fueling the Diabetes Devices Market. Moreover, innovations such as wearable patches and closed-loop insulin pumps are positioning the Diabetes Devices Market for sustained innovation and market expansion.
Market Restraining Factors
Despite its growth potential, the Diabetes Devices Market faces challenges such as high costs associated with advanced monitoring systems and insulin delivery devices. Fragmented reimbursement policies in various regions are limiting market penetration of novel technologies in the Diabetes Devices Market. Additionally, concerns about data privacy and the need for technical training are slowing adoption of digital and connected diabetes devices, potentially restraining the Diabetes Devices Market.
Regional Analysis
Regionally, North America leads the Diabetes Devices Market thanks to well-established healthcare infrastructure and high adoption rates of diabetes management technologies. Europe follows with growing demand for continuous glucose monitoring and regulated reimbursement for diabetes devices. The Asia–Pacific region is rapidly expanding in the Diabetes Devices Market, supported by rising diabetes prevalence, increasing healthcare access, and growing middle-class demand. Meanwhile, Latin America and the Middle East & Africa show gradual growth in the Diabetes Devices Market, driven by improving healthcare policies and expanding awareness initiatives.
Key Industry Developments:
May 2021 – Medtronic announced receiving European approval for two of its diabetes management devices. The first, InPen, is a connected insulin pen developed for individuals requiring multiple daily injections. The second, the Guardian 4 sensor, is designed for use as a standalone continuous glucose monitor or in combination with the InPen. Both devices have been CE marked, marking a significant step in expanding Medtronic’s diabetes care portfolio in Europe.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner,
Mahalunge Road, Baner, Pune – 411045,
Maharashtra, India.
Phone:
US :+1 833 909 2966 ( Toll Free )
UK : +44 808 502 0280 ( Toll Free )
APAC: +91 744 740 1245
Email: [email protected]